JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB40870

Anti-GSK3 alpha antibody [EP793Y]

  • 20ul selling size
  • RabMAb
  • Recombinant
  • KO Validated
  • What is this?

4

(1 Review)

|

(17 Publications)

Rabbit Recombinant Monoclonal GSK3 alpha antibody. Suitable for IHC-P, WB, ICC/IF and reacts with Human, Mouse, Rat samples. Cited in 17 publications.

View Alternative Names

Glycogen synthase kinase-3 alpha, GSK-3 alpha, Serine/threonine-protein kinase GSK3A, GSK3A

5 Images
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-GSK3 alpha antibody [EP793Y] (AB40870)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-GSK3 alpha antibody [EP793Y] (AB40870)

ab4870 at 1/50 dilution, staining GSK3 alpha in Human breast carcinoma tissue by Immunohistochemistry, Paraffin embedded section.

Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.

Immunocytochemistry/ Immunofluorescence - Anti-GSK3 alpha antibody [EP793Y] (AB40870)
  • ICC/IF

Lab

Immunocytochemistry/ Immunofluorescence - Anti-GSK3 alpha antibody [EP793Y] (AB40870)

Immunocytochemistry/ Immunofluorescence analysis of HeLa (human cervix adenocarcinoma epithelial cell) cells labeling GSK3 alpha with purified ab40870 at 1/200 dilution (10 μg/mL). Cells were fixed in 100% Methanol. Goat anti rabbit IgG (Alexa Fluor® 488, ab150077) was used as the secondary antibody at 1/1000 (2 μg/mL) dilution. DAPI (blue) was used as nuclear counterstain.

Western blot - Anti-GSK3 alpha antibody [EP793Y] (AB40870)
  • WB

Lab

Western blot - Anti-GSK3 alpha antibody [EP793Y] (AB40870)

Lanes 1-4 : Merged signal (red and green). Green - ab40870 observed at 51 kDa. Red - loading control ab8245 observed at 36 kDa.

ab40870 Anti-GSK3 alpha antibody [EP793Y] was shown to specifically react with GSK3 alpha in wild-type HEK-293T cells. Loss of signal was observed when knockout cell line ab266742 (knockout cell lysate ab257979) was used. Wild-type and GSK3 alpha knockout samples were subjected to SDS-PAGE. ab40870 and Anti-GAPDH antibody [6C5] - Loading Control (ab8245) were incubated overnight at 4°C at 1 in 1000 dilution and 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.

All lanes:

Western blot - Anti-GSK3 alpha antibody [EP793Y] (ab40870) at 1/1000 dilution

Lane 1:

Wild-type HEK-293T (Human epithelial cell line from embryonic kidney transformed with large T antigen) whole cell lysate at 20 µg

Lane 2:

Western blot - Human GSK3A (GSK3 alpha) knockout HEK-293T cell lysate (<a href='/en-us/products/cell-lysates/human-gsk3a-gsk3-alpha-knockout-hek-293t-cell-lysate-ab257979'>ab257979</a>) at 20 µg

Lane 3:

HeLa (Human epithelial cell line from cervix adenocarcinoma) whole cell lysate at 20 µg

Lane 4:

HepG2 (Human liver hepatocellular carcinoma cell line) whole cell lysate at 20 µg

Secondary

All lanes:

Western blot - Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-irdye-800cw-preadsorbed-ab216773'>ab216773</a>) at 1/10000 dilution

Predicted band size: 51 kDa

Observed band size: 51 kDa

false

Western blot - Anti-GSK3 alpha antibody [EP793Y] (AB40870)
  • WB

Supplier Data

Western blot - Anti-GSK3 alpha antibody [EP793Y] (AB40870)

Lane 1 : Wild-type HAP1 whole cell lysate (20 μg)
Lane 2 : GSK3 alpha knockout HAP1 whole cell lysate (20 μg)
Lane 3 : HeLa whole cell lysate (20 μg)
Lane 4 : HepG2 whole cell lysate (20 μg)

Lanes 1 - 4 : Merged signal (red and green). Green - ab40870 observed at 51 kDa. Red - loading control, ab8245, observed at 37 kDa.

ab40870 was shown to specifically react with GSK3 alpha in wild-type HAP1 cells. No band was observed when GSK3 alpha knockout samples were examined. Wild-type and GSK3 alpha knockout samples were subjected to SDS-PAGE. ab40870 and ab8245 (Mouse anti-GAPDH loading control) were incubated overnight at 4°C at a 1/5000 dilution and 1/10,000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed ab216773 and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed ab216776 secondary antibodies at 1/10,000 dilution for 1 hour at room temperature before imaging.

All lanes:

Western blot - Anti-GSK3 alpha antibody [EP793Y] (ab40870)

Predicted band size: 51 kDa

false

Western blot - Anti-GSK3 alpha antibody [EP793Y] (AB40870)
  • WB

Unknown

Western blot - Anti-GSK3 alpha antibody [EP793Y] (AB40870)

All lanes:

Western blot - Anti-GSK3 alpha antibody [EP793Y] (ab40870) at 1/5000 dilution

All lanes:

10ug HeLa cell lysate.

Predicted band size: 51 kDa

Observed band size: 51 kDa

false

  • Carrier free

    Anti-GSK3 alpha antibody [EP793Y] - BSA and Azide free

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

EP793Y

Isotype

IgG

Carrier free

No

Reacts with

Human

Applications

IHC-P, WB, ICC/IF

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "", "IHCP-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/5000", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "1/200", "ICCIF-species-notes": "<p></p>" }, "Mouse": { "IHCP-species-checked": "predicted", "IHCP-species-dilution-info": "", "IHCP-species-notes": "", "WB-species-checked": "guaranteed", "WB-species-dilution-info": "", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "predicted", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "" }, "Rat": { "IHCP-species-checked": "predicted", "IHCP-species-dilution-info": "", "IHCP-species-notes": "", "WB-species-checked": "guaranteed", "WB-species-dilution-info": "", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "predicted", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "" } } }

Product details

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.2 - 7.4 Preservative: 0.05% Sodium azide Constituents: 50% Tissue culture supernatant, 40% Glycerol (glycerin, glycerine), 9.85% Tris glycine, 0.1% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

Glycogen synthase kinase 3 alpha (GSK3 alpha) is a serine/threonine protein kinase also known as GSK3A with a molecular mass of approximately 51 kDa. It plays an important role in the regulation of various cellular processes. GSK3 alpha is expressed in many tissues but has high levels in the brain heart and skeletal muscle. It participates in the phosphorylation of numerous substrates impacting their activity and stability.
Biological function summary

GSK3 alpha influences several cellular functions including cell division differentiation and apoptosis. It functions independently or as part of a protein complex often forming dimeric complexes with GSK3 beta. GSK3 alpha alters the activity of numerous transcription factors and regulates insulin and Wnt signaling pathways affecting glucose metabolism and cellular growth.

Pathways

GSK3 alpha is involved in the Wnt and insulin signaling pathways. In the Wnt pathway GSK3 alpha phosphorylates beta-catenin marking it for degradation and controlling gene expression. In the insulin pathway it modulates glycogen synthesis and affects glucose homeostasis. GSK3 alpha interacts closely with proteins like APC and glycogen synthase making it integral to these pathways.

GSK3 alpha links to neurodegenerative disorders and diabetes. Its dysfunction contributes to Alzheimer’s disease where abnormal phosphorylation of tau protein occurs. In the context of diabetes GSK3 alpha influences glucose regulation impacting insulin sensitivity and action. The interplay between GSK3 alpha and tau in Alzheimer's as well as insulin signaling proteins illustrates its important role in these disease pathways.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Constitutively active protein kinase that acts as a negative regulator in the hormonal control of glucose homeostasis, Wnt signaling and regulation of transcription factors and microtubules, by phosphorylating and inactivating glycogen synthase (GYS1 or GYS2), CTNNB1/beta-catenin, APC and AXIN1 (PubMed : 11749387, PubMed : 17478001, PubMed : 19366350). Requires primed phosphorylation of the majority of its substrates (PubMed : 11749387, PubMed : 17478001, PubMed : 19366350). Contributes to insulin regulation of glycogen synthesis by phosphorylating and inhibiting GYS1 activity and hence glycogen synthesis (PubMed : 11749387, PubMed : 17478001, PubMed : 19366350). Regulates glycogen metabolism in liver, but not in muscle (By similarity). May also mediate the development of insulin resistance by regulating activation of transcription factors (PubMed : 10868943, PubMed : 17478001). In Wnt signaling, regulates the level and transcriptional activity of nuclear CTNNB1/beta-catenin (PubMed : 17229088). Facilitates amyloid precursor protein (APP) processing and the generation of APP-derived amyloid plaques found in Alzheimer disease (PubMed : 12761548). May be involved in the regulation of replication in pancreatic beta-cells (By similarity). Is necessary for the establishment of neuronal polarity and axon outgrowth (By similarity). Through phosphorylation of the anti-apoptotic protein MCL1, may control cell apoptosis in response to growth factors deprivation (By similarity). Acts as a regulator of autophagy by mediating phosphorylation of KAT5/TIP60 under starvation conditions which activates KAT5/TIP60 acetyltransferase activity and promotes acetylation of key autophagy regulators, such as ULK1 and RUBCNL/Pacer (PubMed : 30704899). Negatively regulates extrinsic apoptotic signaling pathway via death domain receptors. Promotes the formation of an anti-apoptotic complex, made of DDX3X, BRIC2 and GSK3B, at death receptors, including TNFRSF10B. The anti-apoptotic function is most effective with weak apoptotic signals and can be overcome by stronger stimulation (By similarity). Phosphorylates mTORC2 complex component RICTOR at 'Thr-1695' which facilitates FBXW7-mediated ubiquitination and subsequent degradation of RICTOR (PubMed : 25897075).
See full target information Glycogen synthase kinase-3 alpha

Publications (17)

Recent publications for all applications. Explore the full list and refine your search

Nature communications 16:8857 PubMed41053170

2025

Discovery of a CNS active GSK3 degrader using orthogonally reactive linker screening.

Applications

Unspecified application

Species

Unspecified reactive species

Andreas Holmqvist,Nur Mehpare Kocaturk,Christina Duncan,Jennifer Riley,Steven Baginski,Graham Marsh,Joel Cresser-Brown,Hannah Maple,Kristiina Juvonen,Gajanan Sathe,Nicola Morrice,Calum Sutherland,Kevin D Read,William Farnaby

Cell death & disease 15:229 PubMed38509077

2024

METTL3-dependent mA modification of PSEN1 mRNA regulates craniofacial development through the Wnt/β-catenin signaling pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Lan Ma,Xi Zhou,Siyue Yao,Xinyu Zhang,Ji Mao,Barbara Vona,Liwen Fan,Shu Lou,Dandan Li,Lin Wang,Yongchu Pan

Emerging microbes & infections 11:391-405 PubMed34985411

2022

Pharmacological suppression of glycogen synthase kinase-3 reactivates HIV-1 from latency via activating Wnt/β-catenin/TCF1 axis in CD4 T cells.

Applications

Unspecified application

Species

Unspecified reactive species

Jing Wen,Xin Li,Qing-Xia Zhao,Xiao-Fan Yang,Meng-Li Wu,Qihong Yan,Junbiao Chang,Haikun Wang,Xia Jin,Xiao Su,Kai Deng,Ling Chen,Jian-Hua Wang

Frontiers in pharmacology 12:763181 PubMed34955834

2021

Effect of Neurorepair for Motor Functional Recovery Enhanced by Total Saponins From Maxim. Treatment in a Rat Model of Focal Ischemia.

Applications

Unspecified application

Species

Unspecified reactive species

Le Yang,Jian-Feng Lei,Jun-Yao Ouyang,Man-Zhong Li,Yu Zhan,Xue-Feng Feng,Yun Lu,Ming-Cong Li,Lei Wang,Hai-Yan Zou,Hui Zhao

Aging 13:20738-20747 PubMed34453028

2021

Apatinib inhibits the proliferation of gastric cancer cells via the AKT/GSK signaling pathway .

Applications

Unspecified application

Species

Unspecified reactive species

Yi Chen,Nan Chen,Jin Xu,Xindong Wang,Xiaowei Wei,Cuiju Tang,Zhong Duanmu,Junfeng Shi

Human molecular genetics 30:2347-2361 PubMed34270708

2021

Cardiomyocyte-produced miR-339-5p mediates pathology in Duchenne muscular dystrophy cardiomyopathy.

Applications

Unspecified application

Species

Unspecified reactive species

Melanie Gartz,Margaret Beatka,Mariah J Prom,Jennifer L Strande,Michael W Lawlor

Respiratory research 22:146 PubMed33980216

2021

Relationship between long non-coding RNA PCAT-1 expression and gefitinib resistance in non-small-cell lung cancer cells.

Applications

Unspecified application

Species

Unspecified reactive species

Shaojia Wang,Chao Liu,Qing Lei,Zhengwei Wu,Xiangshuai Miao,Debing Zhu,Xu Yang,Na Li,Mingwei Tang,Yan Chen,Weiwei Wang

Journal of molecular medicine (Berlin, Germany) 99:831-844 PubMed33609145

2021

Glycogen synthase kinase 3 alpha/beta deletion induces precocious growth plate remodeling in mice.

Applications

Unspecified application

Species

Unspecified reactive species

Supinder Kour Bali,Dawn Bryce,Carina Prein,James R Woodgett,Frank Beier

Oncology letters 20:219 PubMed32963625

2020

IMPDH2 promotes cell proliferation and epithelial-mesenchymal transition of non-small cell lung cancer by activating the Wnt/β-catenin signaling pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Hao Xu,Hongda Ma,Lifen Zha,Qian Li,Guanghui Yang,Huiming Pan,Xiangping Fei,Xingxiang Xu,Chen Xing,Ladi Zhang

Frontiers in molecular neuroscience 13:81 PubMed32581704

2020

GSK-3β Contributes to Parkinsonian Dopaminergic Neuron Death: Evidence From Conditional Knockout Mice and Tideglusib.

Applications

Unspecified application

Species

Unspecified reactive species

Junyu Li,Shanshan Ma,Jingnan Chen,Kunhua Hu,Yongyi Li,Zeyu Zhang,Zixiang Su,James R Woodgett,Mingtao Li,Qiaoying Huang
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com